Antihyperlipidemic activity of Camellia sinensis leaves in Triton WR-1339 induced albino rats

Pharmacognosy Magazine

Volumn 4, Issue 13, 2008, Pages 60-64

  Saravana Kumar, A ^a   Mazumder, Avijit ^b   Saravanan, V S ^c  

^a NANDHA COLLEGE OF PHARMACY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c Erode Arts College Autonomous   (India)

Author keywords

Camellia sinensis; HDL; Hyperlipidemia; LDL; VLDL

Indexed keywords

CAMELLIA SINENSIS EXTRACT; CHOLESTEROL; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PLANT EXTRACT; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PLANT LEAF; RAT; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 58049127679     PISSN: 09731296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. S.M. Grundy. Cholesterol and coronary heart disease: A new era. J. Am. Med. Assoc. 256: 2849-2858 (1986).
2. G.Davey Smith. Cholesterol lowering and mortality: The importance of considering initial level of risk. Int. Med. J. 306: 1367-1373, Correction: 1648 (1993).
3. R. Saravanan, N. Rajendra Prasad and K.V. Pugalandi . Effect of Piper betle leaf extract on alcoholic toxicity in the rat brain. J. Med. Food. 6: 261-265 (2003).
4. A.Y. Kaesancini and R. M. Krauss. Cardiovascular disease and hyperlipidimemia. Cur. opinion in lipidology. 5: 249-251(1994).
5. G.Davey Smith and J.Pekkanen. Should there be a moratorium on the use of cholesterol lowering drugs? Br. Med J. 304. 431-440(1992).
6. S. L. Brown. Lowered serum cholesterol and low mood. Br. Med. J. 313: 637-638(1996).
7. T. M.Speight and Avery's. Drug treatment Principles and Practice of clinical Pharmacology and therapeutics, (3rd Edition, ADIS press Ltd, 1987). pp.599.
8. J. A.Berliner and J. W. Heinecke . The role of oxidized lipoproteins in atherogenesis. Free. Radic. Biol. Med. 20: 707-727(1996).
9. T. Suzuki and Y. Suzuki. Current topics of lipid dynamics and pathobiology in membrane lipid rafts. Biol. Pharm. Bull. 29(8): 1538-1541(2006).
10. D. H. Ryan. Diet and exercise in the prevention of diabetes. Int. J. Clin. Pract. 134: 28-35(2003).
11. A.Gramza and J. Korezak, Tea constituents (Camellia sinensis L) as antioxidants in lipid systems. Trends in food sci. tech. 16: 351-358(2005).
12. The Tea Council. Available froin http://www.tea.council,co.uk. (2004)
13. A,H.Varnam and H.P.Sutherland.Beverages technology, chemistry and microbiology. (Chapman and Hall Edition, 1994) pp. 126-189.
14. W.C.Evans. Treese and Evans Pharmacognosy, (Balliere, Tindall, Londan 1996) pp.388-433.
15. M.Friedman and S. O. Byers. Mechanism underlying hypercholesterolemia induced by triton WR-1339. Am. J, Physiol. 190: 435-445(1957).
16. Hicham hurnafi, Nour el Houda Bouanani, Mohammed Aziz, Hana Serghini Caid, Noreddine Ghalim and Souliman Amrani. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: A comparision with fenofibrate. J.of.Ethnopharmacol. 109: 156-160(2007).
17. K.Muramatsu, M.Fukuyo and Y.Hara. Effect of green Tea catechins on plasma cholesterol level in cholesterol feed rats. J. Nutr. Sci. Vitaminol. 56: 509-520(1986).
18. Z.Y.Ding, Y.Chen, M.Zhou and Y.Z. Fang. Inhibitory effect of green tea polyphenol and murin on the oxidative modification of low-density lipoprotein. Clim. J. Pharmacol. Toxicol. 6: 263-266(1992).
19. A.Kellner, J.W.Correll and A.T.Ladd. Sustained hyperlipidemia induced in rabbits by means of intravenously injected surface active agents. J.of.Exp.Medicine. 93:373-384(1951).
20. R.H.Fiser, Denniston, R.B.Rindsig and W.R.Beisel. Triglyceride secretion rates: Use of Triton in the rhesus monkey. J.of Nutr. 104:223-226(1974).
21. P.E.Schurr, J.R.Schultz and T.M.Parkinson. Triton induced hyperlipidemia in rats as an animal model for screening hypolidemic drugs. Lipids. 7:69-74(1972).
22. Ye-Yun Li, Chang-Jun Jiang, Xiao-Chun Wan, Zheng-Zhu Zhang and Da-Xiang Li. Purification and partial characterization of β-Glucosidase from fresh leaves of tea plants (Camellia sinensis (L) O.Kuntze. Acta.Biochim.Biophys. Sin. 37(6):364-370(2005).
23. M.E.Harbowy and D.A.Balentine.Tea chemistry. Cri.Rev.in Plant and Sci. 16: 415-480.
24. S.Olway and D.S.Robinson. The effect of the nonionic detergent (Triton) on the removal of triglyceride fatty acids from the blood of the rats. J.of.Physiol. 190:309-319(1967).
25. A.K.Khanna, F.Rizvi and R.Chander. Lipid lowering activity of Phyllanthus niruri in hyperlipidemic rats. J.of.Ethnopharmacol. 82:19-22(2002).
26. J.M.Del Bas, J.Fernandez-Larrea, M.Blay, A.Ardevol, M.J.Arola and C.Blade. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. FASEB. J. 19:479-481(2005).
27. J.Bruneton. Elements de phytochimie et de pharmacognosie, Technique & Documentation Lavoisier, Paris. pp.136-162.
28. M.Sochar, N.Z.Baquer and P.Mclean. Glucose under utilization in Diabetes. Comparative studies on the changes in the activities of enzymes of glucose metabolism in rat kidney and liver. Mol.Physiol. 7: 51-68 (1985).
29. Ji Su Kim, Jung Bong Ju, Chang Won Choi and Sei Chang Kim. Hypoglycemic and Antihyperlipidemic effect of four Korean medicinal plants in alloxan induced diabetic rats. Am.J.of Biochem.Biotech. 2(4):154-160 (2006).
30. Chhanda Mallick, Rajkumar Maiti and Debidas Ghosh. Comparative study on Antihyperglycemic and antihyperlipidemic effects of separate and composite extract of seed of Eugenia jambolana and root of Musa paradisiaca in streptozotocin- induced diabetic male albino rat. Ira.J.of Pharmacol.Therapeu 5: 27-33 (2006).